ABBV-181
ABBV-181 is an anti-PD1 monoclonal antibody that is being developed for combinations with other AbbVie molecules for solid tumors and hematologic malignancies
Type of Molecule
BiologicTarget
anti-PD1Product Type
New Indication| Potential Indication | Region | Phase (1, 2, 3, Submitted) |
|---|---|---|
| Solid Tumors | n/a |
Phase 1
|